Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Serometrix LLC
DescriptionProprotein convertase subtilisin/kexin type 9 (PCSK9) antagonist
Molecular Target Proprotein convertase subtilisin/kexin type 9 (PCSK9)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationHypercholesterolemia
Indication DetailsTreat hypercholesterolemia
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today